Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae

Pneumonia remains the single leading cause of childhood death worldwide. Despite the commercial availability of multiple pneumococcal conjugate vaccines (PCVs), high dosage cost and supply shortages prevent PCV delivery to much of the developing world. The current work presents high-yield pneumococc...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Allison E.B., Gerson, Jonas E., So, Helen Y., Krasznai, Daniel J., St. Hilaire, Adrienne J., Gerson, Donald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625727/
https://www.ncbi.nlm.nih.gov/pubmed/29062961
http://dx.doi.org/10.1016/j.synbio.2016.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625727/
https://www.ncbi.nlm.nih.gov/pubmed/29062961
http://dx.doi.org/10.1016/j.synbio.2016.12.002

Ejemplares similares